Name: Bacopaside X
Rating: 5 (10 reviews)

有库存

sdf 文件

结构编辑

类似物检索

HIT ID:HIT212665292
Cas No:94443-88-6
常用名:Bacopaside X
别名:假马齿苋皂苷 VII, Bacopaside VII
IUPAC:(2S,3R,4S,5S,6R)-2-{[(2S,3R,4S,5S)-3-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-2-{[(1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0^{1,14}.0^{2,11}.0^{5,10}.0^{15,20}]tricosan-7-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
IUPAC:(2S,3R,4S,5S,6R)-2-{[(2S,3R,4S,5S)-3-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5-hydroxy-2-{[(1S,2R,5R,7S,10R,11R,14R,15S,16S,18R,20S)-16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0^{1,14}.0^{2,11}.0^{5,10}.0^{15,20}]tricosan-7-yl]oxy}oxan-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
InChI key:RANQPHKSRUUPKK-GPUGMLHBSA-N

分子式:C46H74O17
分子量:899.081
氢键供体数 (HBD):9
氢键受体数 (HBA):17
LogP:0.86952084
SMILES:[#6]\[#6](-[#6])=[#6]\[#6@H]-1-[#6][C@]([#6])([#8])[#6@@H]2-[#6@H]3-[#6]-[#6]-[#6@@H]4[C@@]5([#6])[#6]-[#6]-[#6@H](-[#8]-[#6@@H]-6-[#8]-[#6]-[#6@H](-[#8])-[#6@H](-[#8]-[#6@@H]-7-[#8]-[#6@H](-[#6]-[#8])-[#6@@H](-[#8])-[#6@H](-[#8])-[#6@H]-7-[#8])-[#6@H]-6-[#8]-[#6@@H]-6-[#8]-[#6@@H](-[#6]-[#8])-[#6@H](-[#8])-[#6@H]-6-[#8])C([#6])([#6])[#6@@H]5-[#6]-[#6][C@@]4([#6])[C@@]33[#6]-[#8][C@@]2([#6]3)[#8]1
SMILES:[#6]\[#6](-[#6])=[#6]\[#6@H]-1-[#6][C@]([#6])([#8])[#6@@H]2-[#6@H]3-[#6]-[#6]-[#6@@H]4[C@@]5([#6])[#6]-[#6]-[#6@H](-[#8]-[#6@@H]-6-[#8]-[#6]-[#6@H](-[#8])-[#6@H](-[#8]-[#6@@H]-7-[#8]-[#6@H](-[#6]-[#8])-[#6@@H](-[#8])-[#6@H](-[#8])-[#6@H]-7-[#8])-[#6@H]-6-[#8]-[#6@@H]-6-[#8]-[#6@@H](-[#6]-[#8])-[#6@H](-[#8])-[#6@H]-6-[#8])C([#6])([#6])[#6@@H]5-[#6]-[#6][C@@]4([#6])[C@@]33[#6]-[#8][C@@]2([#6]3)[#8]1

Bacopaside X (Standard) 是 Bacopaside X 的标准品。适用于定量分析、质量控制及生化实验等相关研究。Bacopaside X 是从 Bacopa monniera 中分离得到的一种三萜皂苷，具显著的抗真菌及抗癌活性。研究表明，其能够有效抑制致病真菌 Candida albicans、Cryptococcus neoformans 和 Aspergillus fumigatus 的生长（MIC = 50 µg/ml），并对多种癌细胞株（MDA-MB-231、SHG44、HCT8、A549、PC3M）表现出显著的增殖抑制作用，IC50 分别为 14.3、15.9、9.8、9.7 和 10.1 µM。此外，在 S180 肉瘤小鼠同系移植模型中，以 50 µmol/kg 剂量处理可降低肿瘤生长 84.13%，显示出较高的药物潜力。

市场产品/服务共显示2个结果

您无法确定哪种化合物库最适合您的项目？或者您需要定制解决方案？Anymole随时为您提供帮助。

电话：400820-0310

合作：info@screeningcompound.com

技术支持：tech@screeningcompound.com

客服：service@screeningcompound.com

正在加载 ~